TMCnet News
Research and Markets: Parkinson's Disease Partnering Deals and Agreements Analysis Report 2010-2015Research and Markets (http://www.researchandmarkets.com/research/3vkjs3/parkinsons) has announced the addition of the "Parkinson's Disease Partnering 2010-2015" report to their offering. The Parkinson's disease Partnering 2010-2015 provides understanding and access to the parkinson's disease partnering deals and agreements entered into by the worlds leading healthcare companies. The report provides an analysis of parkinson's disease partnering deals. The majority of deals are discovery or development stage whereby the licensee obtains a right or an option right to license the licensors parkinson's disease technology. These deals tend to be multicomponent, starting with collaborative R&D, and commercialization of outcomes. Understanding the flexibilty of a prospective partner's negotiated deals terms provides critical insight into the negotiation process in terms of what you can expect to achieve during the negotiation of terms. Whilst many smaller companies will be seeking details of the payments clauses, the devil is in the detail in terms of how payments are triggered - contract documents provide this insight where press releases do not. This data driven report contains over 190 links to online copies of actual parkinson's disease deals and contract documents as submitted to the Securities Exchange Commission by companies and their partners, where available. Contract documents provide the answers to numerous questions about a prospective partner's flexibility on a wide range of important issues, many of which will have a significant impact on each party's ability to derive value from the deal. This data driven report includes:
In Parkinson's disease Partnering 2010-2015, the available deals are listed by:
For more information visit http://www.researchandmarkets.com/research/3vkjs3/parkinsons
|
